John Orwin (Atreca Inc. (Nasdaq: BCEL))

Orwin, John (Atreca 201901 CEO before Genentech + Tibotec)

	Organisation	Genentech Inc.
	Group	Roche (Group)
	Product	cancer immunotherapy (immuno-oncology, I-O)
	Product 2	personalised medicine / precision medicine

Record changed: 2023-11-15

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)